Cytosorbents Corporation (CTSO) vs Flag Ship Acquisition Corp (PMI)

Cytosorbents Corporation and Flag Ship Acquisition Corp are both Medical Devices companies. Cytosorbents Corporation is the larger, with a market value of $13.6M against $11.1M — 1.2× the size. Cytosorbents Corporation has negative trailing earnings, so its P/E is not meaningful; Flag Ship Acquisition Corp trades at 0.2×. Flag Ship Acquisition Corp grew revenue faster over the last twelve months: 45.5% against 3.07%. Cytosorbents Corporation has the higher net margin (−48.9% vs −419.8%) and the higher return on invested capital (−66.9% vs −410.8%). Across the 16 metrics below, Cytosorbents Corporation leads on 11 and Flag Ship Acquisition Corp on 5.

Valuation

Metric CTSO PMI Medical Devices median
P/E n/m 0.17 22.18
P/S 0.37 1.36 2.70
P/B n/m 5.00 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 0.71 1.47 2.38
Earnings yield (132.42%) 597.06% (8.22%)
Free cash flow yield (68.50%) (187.12%) (7.80%)

Profitability

Metric CTSO PMI Medical Devices median
Gross margin 71.61% 18.62% 56.01%
Operating margin (34.74%) (248.37%) (15.03%)
Net margin (48.94%) (419.78%) (20.40%)
Free cash flow margin (25.32%) (254.93%) (7.24%)
Return on equity (336.17%) 100.11% (15.32%)
Return on assets (42.38%) (253.16%) (19.72%)
Return on invested capital (66.90%) (410.80%) (10.33%)

Growth

Metric CTSO PMI Medical Devices median
Revenue growth (TTM) 3.07% 45.47% 8.80%
EPS growth (last fiscal year) 65.79% 74.92% —
Revenue growth, 5-year CAGR (2.00%) — 15.23%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CTSO PMI Medical Devices median
Debt to equity (22.96) 0.41 0.07
Current ratio 0.66 1.02 2.50
Net debt to EBITDA (0.85) 1.27 0.49

Dividend

Metric CTSO PMI Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 — 0.00

Size

Metric CTSO PMI Medical Devices median
Market cap 13.55m 11.05m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack